Innovative Eyewear, Inc. (LUCY)
(Delayed Data from NSDQ)
$0.19 USD
0.00 (-2.11%)
Updated May 23, 2024 04:00 PM ET
After-Market: $0.18 -0.01 (-3.23%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Innovative Eyewear, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 1 | 1 | 0 | NA |
Cost Of Goods | 1 | 1 | 1 | 0 | NA |
Gross Profit | 0 | 0 | 0 | 0 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 7 | 6 | 3 | 0 | 0 |
Income After Depreciation & Amortization | -7 | -6 | -3 | -1 | 0 |
Non-Operating Income | 0 | 0 | 0 | 0 | NA |
Interest Expense | 0 | 0 | 0 | 0 | NA |
Pretax Income | -7 | -6 | -3 | -1 | NA |
Income Taxes | 0 | 0 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | -7 | -6 | -3 | -1 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | -7 | -6 | -3 | -1 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -7 | -6 | -3 | -1 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | NA |
Income After Depreciation & Amortization | -7 | -6 | -3 | -1 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 10.52 | NA | 5.25 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.63 | NA | -0.62 | NA | NA |
Diluted Net EPS (GAAP) | -0.63 | -0.87 | -0.62 | NA | NA |
Fiscal Year end for Innovative Eyewear, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 0.38 | 0.62 | 0.22 | 0.17 | 0.14 |
Cost Of Goods | 0.38 | 0.80 | 0.14 | 0.20 | 0.13 |
Gross Profit | 0.01 | -0.18 | 0.08 | -0.03 | 0.01 |
SG&A, R&D, and Dept/Amort Expenses | 2.03 | 2.31 | 1.67 | 1.31 | 1.44 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.02 | -2.49 | -1.59 | -1.34 | -1.43 |
Non-Operating Income | 0.04 | 0.10 | 0.05 | 0.05 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -1.97 | -2.39 | -1.55 | -1.29 | -1.43 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -1.97 | -2.39 | -1.55 | -1.29 | -1.43 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.97 | -2.39 | -1.55 | -1.29 | -1.43 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 12.95 | 12.36 | 12.92 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.15 | -0.19 | -0.12 | NA | NA |
Diluted Net EPS (GAAP) | -0.15 | -0.17 | -0.12 | -0.15 | -0.19 |